ALDH2 rs671 Variant Lowers Blood Pressure Via the Endothelial HSPA5–PIEZO1–eNOS Pathway
Background The inactivating ALDH2 rs671 polymorphism, present in ≈8% of the global population and up to 30% to 50% of East Asian individuals, has been negatively associated with hypertension. However, the direct role of ALDH2 (aldehyde dehydrogenase 2) dysfunction in this association, as well as the...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Wiley
2026-01-01
|
| Cyfres: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.ahajournals.org/doi/10.1161/JAHA.124.040121 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
